Evidence map›Paper›PMID 40696589›Full record

ArticleMedicine2025

Deliberate dietary adjustments may not mitigate the progression of glaucoma: A two-sample Mendelian randomization study.

Bin Lin, Long-Long Chen, Meng Xu, Dong-Kan Li

Abstract read
In one paragraph

Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bin LinXiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.ORCID 0000-0002-8488-6560
Long-Long ChenXiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.
Meng XuXiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.
Dong-Kan LiXiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ocular diseases, including glaucoma, are significant contributors to visual impairment and irreversible blindness, impacting individuals' socioeconomic opportunities and quality of life. This study aimed to investigate the causal relationship between dietary components and glaucoma progression. We conducted Mendelian randomization studies to assess the effects of 4 dietary components (protein, carbohydrates, sugar, and fat) on glaucoma. A total of 11,417,548 single nucleotide polymorphisms (SNPs) were screened, and after applying a stringent threshold, we retained relevant SNP markers for each dietary group. We employed 4 regression models: MR-Egger regression, a weighted median estimator, an inverse-variance weighted random-effects model, and a weighted model to analyze the data. The analysis revealed that all obtained P-values were greater than .05, indicating no significant association between dietary components and glaucoma. Additionally, sensitivity analyses using the leave-one-out method confirmed the robustness of these findings, showing that the removal of any SNP did not alter the conclusions. The findings suggest that deliberate dietary adjustments may not mitigate the progression of glaucoma. For now, adhering to prescribed medications and considering early surgical intervention when necessary may represent more effective treatments for glaucoma.

Indexed as

DietGlaucomaDietary CarbohydratesDisease ProgressionHumansMendelian Randomization AnalysisPolymorphism, Single NucleotideDietary CarbohydratescarbohydratedietaryfatglaucomaMendelian randomizationproteinsugar

Identifiers

PMID40696589
PMCPMC12282699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.